local_hospital

GYNEKOLOGIE Sottner s.r.o.

Address
Vystavni 9, Stare Brno, 603 00 Brno-střed, Czechia

Female Urogenital Diseases and Pregnancy Complications

The department focuses on Female Urogenital Diseases and Pregnancy Complications, studying how new hormonal methods can support prevention of pregnancy while ensuring safety and tolerability.

  • Contraceptive efficacy of the Levonorgestrel Vaginal Delivery System (LVDS)
  • Comparison of LVDS with oral desogestrel tablets
  • Long‑term safety monitoring across multiple treatment cycles

Research at GYNEKOLOGIE Sottner s.r.o. involves two investigators and contributes to advancing women’s reproductive health in Brno.

Reproductive and Urinary Physiological Phenomena

Studies target Reproductive and Urinary Physiological Phenomena, especially Stress Urinary Incontinence in women with excess weight, evaluating innovative oral agents to reduce incontinence episodes.

  • Efficacy of orforglipron in reducing weekly incontinence episode frequency
  • Effect of obesity or overweight status on treatment outcomes
  • Patient‑reported quality‑of‑life improvements

The site’s multidisciplinary approach aims to improve daily living for affected women while expanding therapeutic options.

Site Overview

assignment
3
connected trials
corporate_fare
2
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 634 other sites in Czechia

description
Trial volume
3
Outperforms 59% of sites
public
Therapeutic diversity
2areas
Outperforms 63% of sites
groups
Sponsor diversity
2sponsors
Outperforms 50% of sites

Therapeutic Area Benchmark — Czechia

Select a therapeutic area to compare against other sites in Czechia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Czechia

Market Share

Country: Czechia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in GYNEKOLOGIE Sottner s.r.o.

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.Chemo Research S.L.Phase IIINot RecruitingJul 2023Aug 2025

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Levonorgestrel2Unknown2023-07-122023-07-12

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.